Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-21-013456

Options or other derivatives

  • Director acquired 230,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Titterton Lewis H jr · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-01 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +30,000 30,000 D
2021-06-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/ownership.xml…